Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Immunome Inc.IMNM · Entity 4219 | Director | June 08, 2023 | June 12, 2023 |
| LIGAND PHARMACEUTICALS INCLGND · Entity 3825 | Director | June 10, 2026 | June 12, 2026 |
| Larimar Therapeutics, Inc.ZFGN · Entity 5634 | Director | June 26, 2019 | June 27, 2019 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Director | May 24, 2006 | May 25, 2006 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Immunome Inc.
Report date June 08, 2023 · Filed June 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.84 · Expires 2033-06-08 | Direct | 6,500 |
Reported balance
After 2023-06-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-08 · Grant · Acquired 6,500 · Balance 6,500 F1: The shares subject to the options shall vest 25% every quarter after the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the options shall vest 25% every quarter after the grant date.
LIGAND PHARMACEUTICALS INC
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,969 |
Ending reported balance
After 2026-06-10 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-06-10 · Sale · Disposed 257 · Balance 31,303 F1: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $246.6300 to $247.6100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-06-10 · Sale · Disposed 232 · Balance 31,071 F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $247.9400 to $248.3350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-06-10 · Sale · Disposed 697 · Balance 30,374 F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $249.3400 to $250.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-06-10 · Sale · Disposed 3,405 · Balance 26,969 F4: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $250.9100 to $251.8950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $246.6300 to $247.6100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $247.9400 to $248.3350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $249.3400 to $250.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $250.9100 to $251.8950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Larimar Therapeutics, Inc.
Report date June 26, 2019 · Filed June 27, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2029-06-26 | Direct | 27,000 |
Reported balance
After 2019-06-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-26 · Grant · Acquired 27,000 · Balance 27,000 F1: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 26, 2020 or the date of the 2020 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 26, 2020 or the date of the 2020 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company.
THERMO FISHER SCIENTIFIC INC.
Report date May 24, 2006 · Filed May 25, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.75 · Expires 2013-05-24 | Direct | 10,500 |
Reported balance
After 2006-05-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2006-05-24 · Grant · Acquired 10,500 · Balance 10,500 F1: The option vests in three equal annual installments beginning on May 24, 2007. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in three equal annual installments beginning on May 24, 2007.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date October 15, 2007 · Filed October 17, 2007
Section 16 reporting ended · disclosed 2007-10-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 57,875 |
Reported balance
After 2007-10-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2007-10-15 · Grant · Acquired 214 · Balance 57,875 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 219,500 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0000078003-05-000048 · lam877.xml · derivative · entry 6 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,500 Underlying: Common Stock · 219,500 shares Expires 2015-02-26 F3 · derivative.exercise_date: This option becomes exercisable in 3 equal annual installments beginning on February 24, 2008. Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 21,651 | $26.20 | $567,256.20 |
DisclosureSEC source: 0000078003-05-000048 · lam877.xml · nonDerivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,381 Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 61,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-05-000048 · lam877.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,032 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:18 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 201 | $26.89 Strike: $0.00 | $5,404.89 |
DisclosureSEC source: 0000078003-05-000009 · lam853.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,884 Underlying: Common Stock · 201 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2004 Filed Dec 17, 2004 19:08 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 168 | $28.32 Strike: $0.00 | $4,757.76 |
DisclosureSEC source: 0000078003-04-000379 · lam842.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,683 Underlying: Common Stock · 168 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 30, 2004 Filed Dec 2, 2004 14:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 179 | $27.77 Strike: $0.00 | $4,970.83 |
DisclosureSEC source: 0000078003-04-000359 · lam830.xml · derivative · entry 5 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,515 Underlying: Common Stock · 179 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 30, 2004 Filed Dec 2, 2004 14:38 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000359 · lam830.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,736 Read SEC document |
| November 15, 2004 Filed Nov 17, 2004 18:39 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 384 | $27.62 Strike: $0.00 | $10,606.08 |
DisclosureSEC source: 0000078003-04-000345 · lam817.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,336 Underlying: Common Stock · 384 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 02, 2004 Filed Nov 3, 2004 20:50 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 4,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000331 · lam809.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,236 Read SEC document |
| October 29, 2004 Filed Nov 2, 2004 15:53 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 172 | $28.95 Strike: $0.00 | $4,979.40 |
DisclosureSEC source: 0000078003-04-000327 · lam805.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,952 Underlying: Common Stock · 172 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2004 Filed Oct 19, 2004 13:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 185 | $28.50 Strike: $0.00 | $5,272.50 |
DisclosureSEC source: 0000078003-04-000316 · lam795.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,780 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2004 Filed Oct 4, 2004 13:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 170 | $30.60 Strike: $0.00 | $5,202.00 |
DisclosureSEC source: 0000078003-04-000302 · lam785.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,595 Underlying: Common Stock · 170 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2004 Filed Sep 17, 2004 14:24 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 163 | $31.85 Strike: $0.00 | $5,191.55 |
DisclosureSEC source: 0000078003-04-000276 · lam766.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,425 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 31, 2004 Filed Sep 1, 2004 17:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 146 | $32.67 Strike: $0.00 | $4,769.82 |
DisclosureSEC source: 0000078003-04-000263 · lam756.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,262 Underlying: Common Stock · 146 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 13, 2004 Filed Aug 17, 2004 17:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 316 | $31.15 Strike: $0.00 | $9,843.40 |
DisclosureSEC source: 0000078003-04-000249 · lam746.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,116 Underlying: Common Stock · 316 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 30, 2004 Filed Aug 2, 2004 19:13 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 159 | $31.96 Strike: $0.00 | $5,081.64 |
DisclosureSEC source: 0000078003-04-000235 · lam736.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800 Underlying: Common Stock · 159 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 15, 2004 Filed Jul 19, 2004 15:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 157 | $32.58 Strike: $0.00 | $5,115.06 |
DisclosureSEC source: 0000078003-04-000217 · lam725.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,641 Underlying: Common Stock · 157 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 17:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 151 | $34.28 Strike: $0.00 | $5,176.28 |
DisclosureSEC source: 0000078003-04-000205 · lam715.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,484 Underlying: Common Stock · 151 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 18, 2004 Filed Jun 22, 2004 14:15 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,072 | $0.00 Strike: $5.71 | $0.00 |
DisclosureSEC source: 0000078003-04-000177 · lam700.xml · derivative · entry 5 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,072 shares Expires 2004-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 3 equal annual installments beginning on August 25,1995. Read SEC document |
| June 18, 2004 Filed Jun 22, 2004 14:15 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 6,072 | $5.71 | $34,671.12 |
DisclosureSEC source: 0000078003-04-000177 · lam700.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2004 Filed Jun 16, 2004 19:42 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 145 | $35.09 Strike: $0.00 | $5,088.05 |
DisclosureSEC source: 0000078003-04-000173 · lam696.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,333 Underlying: Common Stock · 145 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 09, 2004 Filed Jun 10, 2004 19:20 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000162 · lam688.xml · nonDerivative · entry 4 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 12,298 F1 · kind: Gift of 608 shares each to the reporting person's daughter and son. F2 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| June 09, 2004 Filed Jun 10, 2004 19:20 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000162 · lam688.xml · nonDerivative · entry 3 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 5,098 F1 · kind: Gift of 608 shares each to the reporting person's daughter and son. F2 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| June 09, 2004 Filed Jun 10, 2004 19:20 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 1,216 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000162 · lam688.xml · nonDerivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,041 F1 · kind: Gift of 608 shares each to the reporting person's daughter and son. Read SEC document |
| June 09, 2004 Filed Jan 18, 2005 21:34 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001216074-05-000001 · primary_doc.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,603 Read SEC document |
| May 28, 2004 Filed Jun 2, 2004 15:16 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 148 | $35.34 Strike: $0.00 | $5,230.32 |
DisclosureSEC source: 0000078003-04-000158 · lam683.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,188 Underlying: Common Stock · 148 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 18, 2004 Filed May 20, 2004 21:00 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $28.73 | $0.00 |
DisclosureSEC source: 0000097745-04-000075 · lam216.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2011-05-18 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 18, 2005. Read SEC document |
| May 14, 2004 Filed May 18, 2004 14:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 273 | $35.60 Strike: $0.00 | $9,718.80 |
DisclosureSEC source: 0000078003-04-000140 · lam667.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,040 Underlying: Common Stock · 273 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 30, 2004 Filed May 4, 2004 16:40 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 145 | $35.76 Strike: $0.00 | $5,185.20 |
DisclosureSEC source: 0000078003-04-000119 · lam656.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,767 Underlying: Common Stock · 145 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 15, 2004 Filed Apr 19, 2004 15:21 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 144 | $37.34 Strike: $0.00 | $5,376.96 |
DisclosureSEC source: 0000078003-04-000093 · lam631.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,622 Underlying: Common Stock · 144 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 18:09 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 131 | $35.05 Strike: $0.00 | $4,591.55 |
DisclosureSEC source: 0000078003-04-000081 · lam622.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,478 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 25, 2004 Filed Mar 26, 2004 18:46 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000063 · lam605.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,257 F1 · shares: The reported transaction constitutes the grant of restricted stock. Read SEC document |
| March 12, 2004 Filed Mar 16, 2004 18:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 2,253 | $35.29 Strike: $0.00 | $79,508.37 |
DisclosureSEC source: 0000078003-04-000053 · lam596.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,347 Underlying: Common Stock · 2,253 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 09, 2004 Filed Mar 10, 2004 23:53 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0000097745-04-000038 · lam208.xml · derivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2009-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Immediately Read SEC document |
| March 09, 2004 Filed Mar 10, 2004 23:53 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0000097745-04-000038 · lam208.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2004 Filed Mar 10, 2004 16:16 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units (AIP) · Derivative | 233 | $36.90 Strike: $0.00 | $8,597.70 |
DisclosureSEC source: 0000078003-04-000046 · lam588.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 233 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: Immediately. F3 · derivative.expiration_date: Units represent dividend equivalents paid with respect to incentive compensation that had been deferred under the Executive Annual Incentive Plan. Units are settled in cash at a specified later date or upon separation from service. The reported transaction constitutes the disposition of the units through an intra-plan transfer. Read SEC document |
| March 01, 2004 Filed Mar 2, 2004 20:17 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units (AIP) · Derivative | 50,734 | $36.88 Strike: $0.00 | $1,871,069.92 |
DisclosureSEC source: 0000078003-04-000044 · lam586.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,734 shares Expires not disclosed F1 · security: Units represent incentive compensation that has been deferred under the Executive Annual Incentive Plan. Units are settled in cash at a specified later date or upon separation from service. The reported transaction constitutes the disposition of the units through an intra-plan transfer. F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: Immediately. F1 · derivative.expiration_date: Units represent incentive compensation that has been deferred under the Executive Annual Incentive Plan. Units are settled in cash at a specified later date or upon separation from service. The reported transaction constitutes the disposition of the units through an intra-plan transfer. Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 22:08 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $37.15 | $0.00 |
DisclosureSEC source: 0000078003-04-000043 · lam584.xml · derivative · entry 6 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2014-02-26 F3 · derivative.exercise_date: This option becomes exercisable in three equal annual installments beginning on February 26, 2007. Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 22:08 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,633 | $37.15 | $209,265.95 |
DisclosureSEC source: 0000078003-04-000043 · lam584.xml · nonDerivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,488 Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 22:08 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 17,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000043 · lam584.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,121 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.